Klimopoulos S, Katsoulis I E, Margellos V, Nikolopoulou N
2nd Department of Surgery, Evangelismos General Hospital, Athens, Greece.
J R Coll Surg Edinb. 2002 Apr;47(2):485-90.
Sclerosing peritonitis (SCP) is a complication of continuous ambulatory peritoneal dialysis (CAPD) and is characterized by progressive fibrosis of the peritoneum. Entrapment of the intestine in a fibrous sac resulting in complete intestinal obstruction is called sclerosing-encapsulating peritonitis (SEP) and represents the most severe form of the disease. Various reports have been pessimistic regarding the surgical outcome when SEP has caused complete intestinal obstruction. Continuation of CAPD after laparotomy is generally considered not feasible. The aim of this article is to present our experience in the surgical management of SEP and, in particular, in the postoperative continuation of CAPD.
Seventeen consecutive patients with SCP among 175 patients undergoing CAPD during a period of 14 years in a single Unit were retrospectively reviewed. Two groups of patients were recognized. The SCP group included 9 patients with incomplete intestinal obstruction that were treated with single peritoneal catheter removal and switching to haemodialysis. The SEP group included 8 patients with complete obstruction that necessitated laparotomy for surgical debridement of the fibrotic tissue and release of the intestinal loops.
Switching to haemodialysis improved the majority of the group of patients. In 2 of the SEP group of patients (early in the series), where enterectomy was inevitable, performance of an intestinal anastomosis resulted in leakage with subsequent fatal outcome. Two of the SEP group of patients were transferred to haemodialysis after the laparotomy. In the remaining 4 SEP patients (50%), exposure of a significant portion of active peritoneal surface was achieved - called "neoperitonization"-and allowed effective continuation of peritoneal dialysis for an average duration of 16 months (range 1-32).
In patients with SEP, careful release of the intestinal loops avoiding enterectomies and even inadvertent intestinal wounds is mandatory. Continuation of peritoneal dialysis after meticulous debridement and removal of the fibrotic tissue is possible and may be effective. To the best of our knowledge, there have not been previously reported cases of continuations of CAPD after laparotomy for SEP.
硬化性腹膜炎(SCP)是持续性非卧床腹膜透析(CAPD)的一种并发症,其特征为腹膜进行性纤维化。肠管被困于纤维囊内导致完全性肠梗阻称为硬化性包裹性腹膜炎(SEP),是该病最严重的形式。关于SEP导致完全性肠梗阻时的手术结果,各种报告都很悲观。剖腹手术后继续进行CAPD通常被认为不可行。本文的目的是介绍我们在SEP手术治疗方面的经验,特别是在术后继续进行CAPD方面的经验。
回顾性分析了在一个单位14年期间接受CAPD的175例患者中的17例连续性SCP患者。确认了两组患者。SCP组包括9例不完全性肠梗阻患者,采用拔除单个腹膜导管并改为血液透析治疗。SEP组包括8例完全性肠梗阻患者,需要进行剖腹手术以清除纤维化组织并松解肠袢。
改为血液透析使大多数患者病情得到改善。在SEP组的2例患者(该系列早期)中,由于不可避免地需要进行肠切除术,肠吻合术导致渗漏,随后出现致命后果。SEP组的2例患者在剖腹手术后转为血液透析。在其余4例SEP患者(50%)中,实现了大部分活跃腹膜表面的暴露——称为“新腹膜化”——并允许有效地继续进行腹膜透析,平均持续时间为16个月(范围1 - 32个月)。
对于SEP患者,必须小心松解肠袢,避免进行肠切除术甚至意外的肠损伤。在仔细清创和清除纤维化组织后继续进行腹膜透析是可能的,而且可能有效。据我们所知,以前尚未有关于SEP剖腹手术后继续进行CAPD的病例报道。